Hinge Health (NYSE:HNGE) Shares Down 6.1% - What's Next?

Hinge Health Inc. (NYSE:HNGE - Get Free Report) traded down 6.1% during mid-day trading on Monday . The stock traded as low as $43.73 and last traded at $43.80. 78,255 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 1,047,572 shares. The stock had previously closed at $46.63.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Piper Sandler assumed coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued an "overweight" rating and a $41.00 target price on the stock. Needham & Company LLC initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They set a "buy" rating and a $47.00 price objective on the stock. Wall Street Zen upgraded shares of Hinge Health to a "hold" rating in a research report on Monday, June 2nd. KeyCorp assumed coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an "overweight" rating and a $45.00 target price on the stock. Finally, Royal Bank Of Canada assumed coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an "outperform" rating and a $45.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $46.00.

Hinge Health Stock Performance

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.